Under scheme of arrangement between Ranbaxy and Sun Pharma
Sun Pharmaceutical Industries announced that Foreign Investment Promotion Board (FIPB) has, as per the press release dated 28 November 2014 released by FIPB unit of Ministry of Finance, Department of Economic Affairs, approved the proposal of the Company for issuing equity shares of the Company to the non-resident investors of Ranbaxy Laboratories pursuant to the merger of Ranbaxy Laboratories into Sun Pharmaceutical Industries through the scheme of arrangement between Ranbaxy Laboratories and Sun Pharmaceutical Industries.Powered by Capital Market - Live News